Akorn is a niche generic pharmaceutical company engaged in the development, manufacture and marketing of multi-source and branded read more
Sam Boddapati Ph.D. ā Senior Vice President of Regulatory Affairs at Akorn
Executive Bio
Dr. Sam Boddapati, Ph.D. serves as Senior Vice President of Regulatory Affairs at Akorn Inc. Dr. Boddapati, accomplished professional in the pharmaceutical industry with over 25 years of experience, Dr. Boddapati joined Akorn in July 2004 Dr. Boddapati is responsible for filing all regulatory submissions to FDA and obtaining their approvals During his career in the pharmaceutical industry, Dr. Boddapati has filed more than 150 submissions including ANDAs, INDs and NDAs and played a key role in obtaining FDA approval to market the drugs. Prior to joining Akorn, Dr. Boddapati held Senior Management roles at SuperGen, Abraxis BioScience and American Regent.
Executive Team Culture Ratings from Akorn Employees
TOP
30%
Akorn's Executive Team scores in the Top 30%
of similar sized companies on Comparably
of similar sized companies on Comparably
Not Enough Ratings To Show Who Ranks Executive Team the Highest
Anonymously rate my experience at AkornNot Enough Ratings To Show Who Ranks Executive Team the Lowest
Anonymously rate my experience at AkornAkorn's Executive Team at a Glance
Based on 5 ratings, Akorn's employees are satisfied with their Executive Team and give them a āBā or 71/100.
Akorn's Executive Team ranks in the Top 35% of other companies in Chicago and Top 30% of other companies on Comparably that also have 1,001-5,000 Employees.
×